Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...

Pharmacodynamic Models: Overview

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

Pharmacodynamic Models: Linear Concentration–Effect Model

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study.

The Lancet. Infectious diseases·2026

Same author

Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study.

Lancet (London, England)·2026

Same author

Modeling the Impact of Malaria Chemoprevention with sulphadoxine-pyrimethamine on the spread of <i>Plasmodium falciparum dhps</i> A581G mutation.

Infectious Disease Modelling·2026

Same author

Public health impact of catch-up vaccination or additional booster doses with pre-erythrocytic malaria vaccine R21/Matrix-M: a modelling study.

BMC medicine·2026

Same author

Mathematical modeling for analyzing mass drug administration operational factors for efficient malaria incidence reduction in southern Senegal.

Infectious Disease Modelling·2026

Same author

Mapping the prevalence of molecular markers of <i>Plasmodium falciparum</i> artemisinin partial resistance in Africa: a spatial-temporal modelling study.

medRxiv : the preprint server for health sciences·2026

Search research articles

Related Experiment Video

Updated: Mar 13, 2026

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 4, 2007

Mathematical Modelling to Guide Drug Development for Malaria Elimination.

Hannah C Slater¹, Lucy C Okell¹, Azra C Ghani¹

¹MRC Centre for Outbreak Analysis & Modelling, Department of Infectious Disease Epidemiology, Imperial College London, UK.

Trends in Parasitology

|October 12, 2016

Summary

Integrating mathematical models of drug pharmacokinetics and pharmacodynamics (PK/PD) with malaria transmission models is crucial for designing effective antimalarial drugs. This approach aids in optimizing drug development for both individual patient therapy and population-level malaria control.

Keywords:

Plasmodium falciparum Plasmodium vivax drug development drug-based strategies malaria mathematical modelling

More Related Videos

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

Related Experiment Videos

Last Updated: Mar 13, 2026

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Predicting the Effectiveness of Population Replacement Strategy Using Mathematical Modeling

Published on: July 4, 2007

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

Area of Science:

Mathematical modeling
Pharmacokinetics and pharmacodynamics (PK/PD)
Malaria transmission dynamics

Background:

Mathematical models are vital for drug development, primarily assessing patient therapy efficacy and response duration.
Antimalarial drugs are increasingly used at the population level for infection clearance, chemoprevention, and reducing transmission.
The importance of specific drug properties for different population-level uses and the impact of drug resistance require further investigation.

Purpose of the Study:

To highlight the need for integrating within-host PK/PD models with population-level malaria transmission models.
To guide optimal drug design for malaria elimination strategies.
To address the limited understanding of drug properties crucial for population-level antimalarial interventions.

Main Methods:

The study proposes a conceptual framework for integrating PK/PD models with transmission models.
It emphasizes the need for a unified modeling approach.
No new empirical data or simulation results are presented; it's a theoretical argument.

Main Results:

The integration of within-host and population-level models offers a pathway to rational drug design.
This integrated approach can inform the development of antimalarial drugs with improved efficacy for malaria elimination.
Understanding drug properties in the context of transmission is key to combating resistance.

Conclusions:

Integrating PK/PD and transmission models is essential for optimizing antimalarial drug development.
This approach supports the design of drugs that are effective for both individual treatment and population-level control, aiding malaria elimination efforts.
Addressing drug resistance necessitates a holistic view of drug action from the host to the population level.